Retraction notice to “Calebin A downregulates osteoclastogenesis through suppression of RANKL signalling” [Arch. Biochem. Biophys. 593 (2016) 80-89]
Archives of Biochemistry and Biophysics · 2026-11 · 111054
DOI: 10.1016/j.abb.2026.111054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-11. Verfasst von Amit K Tyagi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
- Sabinsa Corporation, East Windsor, NJ, USA.
Zitieren
APA
Tyagi, A. K., Prasad, S., Majeed, M., & Aggarwal, B. B. (2026). Retraction notice to “Calebin A downregulates osteoclastogenesis through suppression of RANKL signalling” [Arch. Biochem. Biophys. 593 (2016) 80-89]. Archives of Biochemistry and Biophysics, 111054. https://doi.org/10.1016/j.abb.2026.111054
Vancouver
Tyagi AK, Prasad S, Majeed M, Aggarwal BB. Retraction notice to “Calebin A downregulates osteoclastogenesis through suppression of RANKL signalling” [Arch. Biochem. Biophys. 593 (2016) 80-89]. Archives of Biochemistry and Biophysics. 2026:111054. doi:10.1016/j.abb.2026.111054
BibTeX
@article{Tyagi2026,
author = {Tyagi, Amit K and Prasad, Sahdeo and Majeed, Muhammed and Aggarwal, Bharat B},
title = {Retraction notice to “Calebin A downregulates osteoclastogenesis through suppression of RANKL signalling” [Arch. Biochem. Biophys. 593 (2016) 80-89]},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
pages = {111054},
doi = {10.1016/j.abb.2026.111054}
}
EUVIMED